Skip to main content
. 2021 Jan 8;9(1):325–334. doi: 10.1007/s40615-020-00960-y

Table 3.

Adjusteda odds ratios (aORs) and 95% confidence intervals (CIs) for association of selected chronic conditions and COVID-19-related hospitalizations among Medicare beneficiaries (MBs) with a confirmed COVID-19 illness, USA, January 1–September 30, 2020

Condition aOR (95% CI)
End-stage renal disease 2.15 (2.10–2.21)
Chronic kidney disease 1.54 (1.52–1.56)
Acute myocardial infarction 1.45 (1.39–1.53)
Heart failure 1.43 (1.41–1.44)
Diabetes 1.37 (1.36–1.39)
Chronic obstructive pulmonary disease 1.36 (1.34–1.38)
Obesity 1.36 (1.34–1.37)
Spina bifida and other congenital anomalies of the nervous system 1.21 (1.10–1.35)
Lung cancer 1.21 (1.15–1.28)
Opioid use disorder 1.19 (1.15–1.23)
Ischemic heart disease 1.27 (1.25–1.28)
Hepatitis 1.15 (1.11–1.20)
Schizophrenia 1.10 (1.08–1.13)
Hypertension 1.24 (1.22–1.25)
Liver disease 1.18 (1.15–1.21)
Atrial fibrillation 1.18 (1.16–1.20)
Cardiovascular diseaseb 1.24 (1.23–1.26)
Anemia 1.21 (1.20–1.22)
Asthma 1.13 (1.11–1.16)
Tobacco 1.03 (1.01–1.05)
Peripheral vascular disease 1.19 (1.17–1.20)
Sickle cell disease 1.55 (1.31–1.82)
Stroke 1.13 (1.11–1.15)
HIV/AIDS 0.88 (0.82–0.94)
Hyperlipidemia 1.12 (1.11–1.14)
Depression 1.07 (1.06–1.08)
Rheumatoid arthritis/osteoarthritis 1.03 (1.02–1.04)
Osteoporosis* 1.00 (0.98–1.02)
Alzheimer disease/dementia* 1.01 (0.99–1.03)

aAdjusted for age, sex, race and ethnicity, and urban-rural residence

bAcute myocardial infarction; atrial fibrillation; heart failure; hypertension; ischemic heart disease; stroke/transient ischemic attack; and peripheral vascular disease

*Not significant for Wald chi-square test at P < .05